Haberl AE - Search Results

1

Risk factors for IRIS in HIV-associated Pneumocystis-pneumonia following ART initiation.

Kann G, Wetzstein N, Bielke H, Schuettfort G, Haberl AE, Wolf T, Kuepper-Tetzel CP, Wieters I, Kessel J, de Leuw P, Bickel M, Khaykin P, Stephan C. Kann G, et al. Among authors: haberl ae. J Infect. 2021 Sep;83(3):347-353. doi: 10.1016/j.jinf.2021.06.027. Epub 2021 Jul 7. J Infect. 2021. PMID: 34242683

2

The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.

Staszewski S, Babacan E, Stephan C, Haberl A, Carlebach A, Gute P, Klauke S, Hermschulte Y, Stuermer M, Dauer B; Frankfurt HIV Cohort. Staszewski S, et al. J Antimicrob Chemother. 2006 Nov;58(5):1024-30. doi: 10.1093/jac/dkl375. Epub 2006 Sep 6. J Antimicrob Chemother. 2006. PMID: 16956902 Clinical Trial.

3

Dose reduction effective in alleviating symptoms of saquinavir toxicity.

Stephan C, Carlebach A, Rottmann C, Haberl A, Dauer B, von Hentig N, Kurowski M, Staszewski S. Stephan C, et al. Int J STD AIDS. 2007 Feb;18(2):81-4. doi: 10.1258/095646207779949763. Int J STD AIDS. 2007. PMID: 17331276

4

Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.

von Hentig N, Nisius G, Lennemann T, Khaykin P, Stephan C, Babacan E, Staszewski S, Kurowski M, Harder S, Haberl A. von Hentig N, et al. Antivir Ther. 2008;13(8):1039-46. Antivir Ther. 2008. PMID: 19195329

5

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Antiretroviral Therapy Cohort Collaboration (ART-CC); Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, Saag M. Antiretroviral Therapy Cohort Collaboration (ART-CC), et al. Clin Infect Dis. 2009 Apr 15;48(8):1138-51. doi: 10.1086/597468. Clin Infect Dis. 2009. PMID: 19275498 Free PMC article.

6

Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting.

Haberl A, Moesch M, Nisius G, Stephan C, Bickel M, Khaykin P, Kurowski M, Brodt R, von Hentig N. Haberl A, et al. Eur J Clin Pharmacol. 2010 Apr;66(4):375-81. doi: 10.1007/s00228-009-0767-8. Epub 2009 Dec 24. Eur J Clin Pharmacol. 2010. PMID: 20033681

7

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients.

Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Von Hentig N, Herrmann E, Doerr HW, Brodt HR, Allwinn R. Bickel M, et al. AIDS. 2010 Jun 1;24(9):F31-5. doi: 10.1097/QAD.0b013e3283398da1. AIDS. 2010. PMID: 20559034

8

Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R.

Stephan C, Dauer B, Bickel M, Haberl A, Locher L, Müller A, Klauke S, Berger A, Doerr HW, Stürmer M, Staszewski S; Frankfurt Cohort Study. Stephan C, et al. J Infect. 2010 Oct;61(4):346-50. doi: 10.1016/j.jinf.2010.06.008. Epub 2010 Jun 19. J Infect. 2010. PMID: 20600301

9

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.

Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients; Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, et al. Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15. Lancet. 2010. PMID: 20638118 Free PMC article.

10

Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Bickel M, von Hentig N, Wieters I, Khaykin P, Nisius G, Haberl A, Stephan C, Herrmann E, Doerr HW, Brodt HR, Allwinn R. Bickel M, et al. Clin Infect Dis. 2011 Jan 1;52(1):122-7. doi: 10.1093/cid/ciq003. Clin Infect Dis. 2011. PMID: 21148530 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page